News

Find News

Filter articles

Applied Filters

Showing 71 to 80 of 1026 results

Takeda faces ‘pay-for-delay’ class-action suit over anti-constipation drug

US05-08-2021Alex Baldwin

Takeda Pharmaceuticals is the target of a proposed class action that alleges the pharma giant paid to keep a generic anti-constipation drug off the market.

FDA approves milestone biosimilar insulin drug

29-07-2021

The US Food and Drug Administration has approved the first-ever interchangeable biosimilar product, an insulin treatment for Types 1 and 2 diabetes.

AstraZeneca loses major generics appeal in India

India22-07-2021Rory O'Neill

The Delhi High Court has cleared the way for a slew of generic diabetes drugs to arrive on the Indian market after it rejected AstraZeneca’s request for a blocking order.

CMA fines drugmakers £260m for 10,000% price hike

15-07-2021

The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.

POTUS orders crackdown on anticompetitive drug practices

US13-07-2021Alex Baldwin

An executive order by President Joe Biden has targeted anti-competitive practices in the US drugs market, including a ban of pay-for-delay agreements.

Taiwanese biotech built on ‘foundation of lies’, says DoJ

08-07-2021Rory O'Neill

US prosecutors have charged the founders of Taiwanese biosimilar manufacturer JHL Biotech with stealing Genentech trade secrets.

Teva sues two Indian generics over Huntington’s treatment

India, US06-07-2021Alex Baldwin

Teva Pharmaceuticals has filed lawsuits in New Jersey against two Indian generics manufacturers to stop them from developing a generic version of its Huntington’s disease treatment.

UK Supreme Court shoots down NHS £220m drug patent suit

UK02-07-2021Alex Baldwin

The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.

Teva and Eagle try to block Bendeka generic

US01-07-2021Rory O'Neill

Teva and Eagle Pharmaceuticals are suing to block a generic version of its leukemia drug Bendeka, arguing its patents still have plenty of time to run.

Class-action accuses Takeda of ‘pay-for-delay’ deal with Par

US01-07-2021Alex Baldwin

Takeda Pharmaceuticals organised a pay-for-delay deal with Par Pharmaceuticals to prevent a generic version of its constipation treatment from releasing, according to a complaint submitted to the US District Court for the District of Massachusetts.

Showing 71 to 80 of 1026 results

LSIPR